This section compares the proposed method with thirteen state-of-the-art benchmark methods on the task of detecting breast cancer metastases on H&E-stained WSIs and calculating HER2 and CEN17 signals on FISH and DISH slides for HER2 target therapy. The gene discussed is ERBB2; the disease is breast carcinoma.